Uptake of influenza vaccine

doi:10.1136/bmj.309.6947.126a

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Epidemic of 1989-90 improved uptake

Jonathan Nguyen-Van-Tam,
Simon Warren,
James Pearson

Lecturer Medical student Senior lecturer Department of Public Health Medicine and Epidemiology, University of Nottingham Medical School, Queen's Medical Centre, Nottingham NG7 2UH.

EDITOR,—Martin Wiselka highlights the low uptake of influenza vaccine among people known to be at increased risk of influenza and its complications.1 In particular, he draws attention to the extremely low uptake in high risk groups between 1983 and 1989, which generally ranged from 5% to 20%. The influenza epidemic that followed in the winter of 1989-90 was the largest since 1976, …